what is glp-1 agonist You Should Know Before Asking for a Prescription The New - GLP-1 receptor

But with innovation come unpredictable variables

Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease

This combination is recommended for individuals with a BMI over 30 (obesity), or individuals with both a BMI of 27 (overweight) or greater with a weight related health problem such as hypertension or diabetes

Thank you

Am J Cardiol 2014;114:384-8.ArticlePubMed 123

Many patients may refer to them by brand name rather than drug class, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Victoza, Saxenda, or other incretin therapies